Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro

Journal of Microbiology and Biotechnology
Wen DaiChun Jiang

Abstract

Herpes simplex virus type 2 (HSV-2) infection has been a public health concern worldwide. It is the leading cause of genital herpes and a contributing factor to cervical cancer and human immunodeficiency virus (HIV) infection. No vaccine is available yet for the treatment of HSV-2 infection, and routinely used synthetic nucleoside analogs have led to the emergence of drug resistance. The small molecule Retro-2cycl has been reported to be active against several pathogens by acting on intracellular vesicle transport, which also participates in the HSV-2 lifecycle. Here, we showed that Retro-2.1, which is an optimized, more potent derivative of Retro-2cycl, could inhibit HSV-2 infection, with 50% inhibitory concentrations of 5.58 μM and 6.35 μM in cytopathic effect inhibition and plaque reduction assays, respectively. The cytotoxicity of Retro-2.1 was relatively low, with a 50% cytotoxicity concentration of 116.5 μM. We also preliminarily identified that Retro-2.1 exerted the antiviral effect against HSV-2 by a dual mechanism of action on virus entry and late stages of infection. Therefore, our study for the first time demonstrated Retro-2.1 as an effective antiviral agent against HSV-2 in vitro with targets distinct from those of...Continue Reading

Citations

May 12, 2020·Frontiers in Microbiology·Lalita PriyamvadaPanayampalli S Satheshkumar
Jul 7, 2020·Frontiers in Cell and Developmental Biology·Valérie Nicolas, Vanessa Lievin-Le Moal
Feb 23, 2020·Nature Chemical Biology·Alison ForresterLudger Johannes
Oct 9, 2020·Journal of Virology·Giulia TebaldiAnthony V Nicola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.